Bruker Corp. Stock
Bruker Corp. Stock
The Bruker Corp. stock is trending slightly upwards today, with an increase of €0.11 (0.240%) compared to yesterday's price.
With 14 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 51 € shows a slightly positive potential of 12.01% compared to the current price of 45.53 € for Bruker Corp..
For the coming years our community has positive and negative things to say abot the Bruker Corp. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 0.240% | -15.764% | -15.686% | 63.912% | 11.351% | -24.926% | - |
| Healthequity Inc. | -0.560% | -0.552% | 8.434% | 15.385% | 15.385% | 45.161% | 45.161% |
| Omnicell Inc. | 0.000% | -14.054% | -14.973% | 22.308% | -18.041% | -45.641% | -74.762% |
| Myriad Genetics | -0.330% | -39.161% | -47.359% | -18.343% | -48.849% | -85.656% | -90.887% |
Comments
Bruker (BRKR) had its price target raised by Leerink Partners from $60.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its "buy" rating reaffirmed by Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target raised by JPMorgan Chase & Co. from $55.00 to $65.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Bruker Q2 Earnings Call Highlights
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose 5.2% year over year to $838.5 million, while non-GAAP operating
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Order momentum is improving across Bruker’s business, with semiconductor metrology, overseas